IM
PAN, Poland
IM
PAN, Poland

Time filter

Source Type

Patent
Yang, Young Ok, Im and Yoo | Date: 2012-09-26

Disclosed herein is a method of preparing a solid ink composition, comprising the steps of: reacting 15 25 parts by weight of base oil including coconut oil, palm oil and castor oil and 40 60 parts by weight of aliphatic organic acid of 10 to 20 carbon atoms with 7 15 parts by weight of a caustic soda solution (concentration: 40%) to saponify the base oil and to change the aliphatic organic acid into sodium salt thereof; mixing 3 10 by weight of glycerin, 10 20 by weight of ethanol, 0.1 1.0 by weight of a dye and 1 10 by weight of silica with the reaction product and then melting the mixture at 70 80C; and cooling the molten mixture. The solid ink composition prepared by the method is very transparent, and has excellent miscibility and stability because it is easily mixed with a water-soluble dye or a water-soluble fluorescent dye.


News Article | February 22, 2017
Site: www.prweb.com

Aligned Energy, an infrastructure technology company that offers cloud, enterprise, and service providers colocation and build-to-scale data center solutions, announced today its position as a Founding Partner of Infrastructure Masons (IM), a not-for-profit organization of industry professionals who design, build and operate the technical infrastructure of the digital age. Technical infrastructure (data center, compute, storage and network) is the backbone of today’s digital economy and an increasingly large part of the total $3.5 trillion global annual IT expenditure, according to IT research firm Gartner. Data center construction alone is expected to increase at a robust 9.3% annually, according to research firm Research and Markets. The immense size and robust growth of this industry can only be sustained by continuing to attract and develop talent across a broad spectrum of necessary skills. Aligned Energy’s mission to solve some of the toughest market challenges that data centers face today is closely aligned with the goals of Infrastructure Masons. As one of the Founding Partners, Aligned Energy will collaborate with the leaders from other top hyper scale companies to tackle these types of industry issues, such as enabling better, more reliable and energy efficient infrastructure inside these mission critical facilities. By activating strategic thinkers from its team, Aligned Energy will help inform the next generation of talent about exciting career opportunities in the field, educate the industry about the power of intelligent infrastructure, mentor and develop fellow Masons and develop new ways to deliver data centers more responsibly and efficiently. “Infrastructure Masons serves as a great mobilizer for education, talent cultivation and collaboration within the industry,” said Jakob Carnemark, founder and CEO of Aligned Energy. “The opportunity to become involved was an easy one for us as many of their initiatives directly compliment the core values we were founded on.” “Building the digital infrastructure today is a project as large, and as important, as the construction of the electric grid in the early 1900s, or the building of the Interstate Highway system in the 1950s,” said Joe Kava, a member of Infrastructure Masons’ End User Advisory Council. “It will have the same breadth of social, economic, and cultural impact as these other great infrastructure projects.” “We are so pleased that Aligned Energy is supporting Infrastructure Masons through the Founding Partner program,” said Mark Monroe, Executive Director of the group. “Jakob will be a great addition to the Partner Advisory Council, and Aligned Energy’s expertise in sustainability, stewardship, and innovation will help drive iMasons’ mission forward as a respected, professional society for digital infrastructure builders.” Aligned Energy’s commitment to evolving data center design for improved reliability, sustainability and scalability for general betterment works hand-in-hand with Infrastructure Masons’ charter to help members connect, grow, and give back. On February 23rd, leaders from Aligned Energy will team up with Infrastructure Masons as they join forces with the Technology Convergence Conference (TCC) in San Jose, CA to provide a powerful day of infrastructure collaboration, networking and education opportunities. About Aligned Energy Aligned Energy is an infrastructure technology company that offers cloud, enterprise, and service providers colocation and build-to-scale data center solutions. Our intelligent infrastructure allows us to deliver data centers as a utility - accessible and consumable in the amount and moment needed. By reducing the energy, water and space needed to operate, our technology innovations offer businesses a competitive advantage by improving reliability and their bottom-line, while helping secure the health of the planet. For more information on Aligned Energy, please visit http://www.alignedenergy.com About Infrastructure Masons Infrastructure Masons is a group of industry professionals who design, build and operate the technical infrastructure of the digital age. The IM community is where professionals connect, grow and give back. Established in April of 2016, iMasons is a 501(c)6, non-profit association of individuals, and assesses levels of industry knowledge based on criteria in three dimensions - Experience, Economics and Stewardship. iMasons is guided by the End User and Partner Advisory Councils, consisting of leaders of some of the largest and most advanced technical infrastructure portfolios in the world. As of January 2017, membership exceeded 1,000 individuals representing over $100Bn in Infrastructure projects in over 130 countries. http://imasons.org.


...un anticorps monoclonal à action prolongée présentement à l'étude dans le traitement du VIH MONTRÉAL, QUÉBEC--(Marketwired - 15 fév. 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd'hui que les données pharmacocinétiques (PC) et pharmacodynamiques (PD) comparant l'administration par voie intramusculaire (IM) à celle par voie intraveineuse (IV) de l'ibalizumab ont été présentées lors de la conférence annuelle sur les rétrovirus et les infections opportunistes (CROI) 2017. La PC et la PD de deux doses d'ibalizumab, 800 mg deux fois par semaine et 2 000 mg toutes les quatre semaines, administrées par voie IM, ont été évaluées au cours de l'étude TMB-121. Ces données ont été comparées à la PC et à la PD de doses similaires d'ibalizumab administrées par voie IV dans une étude antérieure. Les résultats ont démontré que le profil de la PC et de la PD des deux doses d'ibalizumab administrées par IM se comparaient au profil de l'administration par voie IV. L'ibalizumab a été bien toléré qu'il soit administré par IM ou IV. TMB-121 est une étude de Phase I/II randomisée évaluant principalement la PC/PD de l'administration IM de l'ibalizumab. L'étude est effectuée à Taiwan, par notre partenaire TaiMed Biologics inc, et les patients inscrits ont un VIH-1 ARN ≥5 000 copies/mL pour lequel ils n'ont pas reçu de traitement antirétroviral depuis au moins un an. Le principal objectif de l'étude est d'évaluer le profil de la PC et de la PD de l'ibalizumab en utilisant différentes voies d'administration. L'ibalizumab est un anticorps monoclonal humanisé présentement à l'étude et en cours de développement pour le traitement de l'infection par le virus de l'immunodéficience humaine-1 (VIH-1) pluri-résistante aux médicaments. Contrairement aux autres agents antirétroviraux, l'ibalizumab se fixe au domaine extracellulaire secondaire du récepteur des cellules CD4+ T, en restant à l'écart des récepteurs du complexe majeur d'histocompatibilité Classe II. Potentiellement, il prévient l'infection des cellules immunitaires CD4+ T par le VIH tout en conservant les fonctions immunologiques normales. L'ibalizumab démontre une activité contre le VIH-1 résistant à tous les autres agents antirétroviraux présentement approuvés. L'ibalizumab a été testé lors d'études de phase I et II et l'étude de phase III est la dernière étude d'importance nécessaire pour compléter le Biologics License Applications (BLA) prévu être soumis à la Food and Drug Administration (FDA). L'ibalizumab a obtenu la désignation de « percée thérapeutique » de la U.S. Food and Drug Administration (FDA). Cette désignation est accordée dans les cas où une thérapie peut potentiellement offrir une amélioration substantielle par rapport à ce qui est déjà disponible pour le traitement d'une condition grave et mettant la vie en danger. L'ibalizumab a également obtenu de la FDA la désignation de « médicament orphelin ». Theratechnologies (TSX:TH) est une société pharmaceutique spécialisée dans le traitement de besoins médicaux non satisfaits en vue de promouvoir auprès des patients infectés par le VIH un mode de vie sain et une qualité de vie améliorée. D'autres renseignements sur Theratechnologies sont disponibles sur le site Web de la Société au www.theratech.com et sur SEDAR au www.sedar.com. Le présent communiqué de presse renferme des énoncés prospectifs et de l'information prospective (collectivement, les « énoncés prospectifs ») au sens de la législation applicable en valeurs mobilières qui reposent sur les opinions et les hypothèses de la direction et sur l'information dont celle-ci dispose présentement. Vous pouvez identifier les énoncés prospectifs par l'emploi de mots tels que « peut », « va », « pourrait », « voudrait », « devrait », « perspectives », « croit », « planifie », « envisage », « prévoit », « s'attend » et « estime » ou la forme négative de ces termes ou des variations de ceux-ci. Les énoncés prospectifs présents dans ce communiqué de presse incluent notamment le parachèvement et le dépôt d'un BLA auprès de la FDA pour l'ibalizumab et l'approbation de l'ibalizumab pour le traitement des patients atteints d'une infection au VIH-1 PRM. Les énoncés prospectifs sont fondés sur un certain nombre d'hypothèses et sont sujets à des risques et incertitudes dont plusieurs sont hors de la volonté de Theratechnologies et pourraient entrainer un écart marqué entre les résultats réellement obtenus et ceux exprimés, expressément ou implicitement, par de tels énoncés prospectifs. Ces hypothèses incluent notamment que toutes les données requises pour déposer un BLA auprès de la FDA seront disponibles pour supporter un tel dépôt, que l'ibalizumab sera approuvé par la FDA en tant que traitement pour l'infection au VIH-1 PRM et que, si l'ibalizumab est approuvé, Theratechnologies aura, en temps opportun, mis en place l'infrastructure requise pour le lancement et la commercialisation de l'ibalizumab aux États-Unis. Les risques et incertitudes incluent notamment le risque que les toutes les données requises pour déposer un BLA auprès de la FDA ne soient pas suffisamment satisfaisantes pour la soumission d'un BLA, que la FDA n'approuve pas l'ibalizumab en tant que traitement pour l'infection au VIH-1 PRM ou que, si approuvé, que la FDA impose des restrictions importantes à son utilisation, que la FDA exige la tenue d'essais cliniques supplémentaires et que Theratechnologies ne soit pas en mesure de mettre en place l'infrastructure requise pour le lancement et la commercialisation de l'ibalizumab aux États-Unis. Les investisseurs éventuels sont priés de se reporter à la rubrique « Facteurs de risque » de la notice annuelle de la société datée du 7 février 2017 pour plus d'informations sur les risques et incertitudes touchant Theratechnologies. La notice annuelle peut être consultée sur le site web de la société à l'adresse www.theratech.com ou sur le site web SEDAR à l'adresse www.sedar.com. Le lecteur est prié d'examiner ces risques et incertitudes attentivement et de ne pas se fier indûment aux énoncés prospectifs. Les énoncés prospectifs reflètent les attentes actuelles concernant des événements futurs. Ils ne sont valables qu'à la date du présent communiqué de presse et traduisent nos attentes à cette date. Nous ne nous engageons aucunement à mettre à jour ou à réviser l'information contenue dans ce communiqué de presse, que ce soit à la suite de l'obtention de nouveaux renseignements, à la suite de nouveaux événements ou circonstances ou pour toute autre raison que ce soit, sauf si les lois en vigueur l'exigent.


News Article | February 22, 2017
Site: globenewswire.com

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES AXA IM has published the Volta Finance Limited (the "Company" or "Volta Finance" or "Volta") monthly report for January. The full report is attached to this release and is available on Volta's website (www.voltafinance.com). In January, Volta's Estimated NAV* performance was 1.3%, in line with a positive performance in most credit and equity markets. During the month, Volta purchased just one position (a USD CLO Debt tranche) for the equivalent of €1.1m and received the equivalent of €18.4m from four assets that were maturing or called. On average, and based on standard market assumptions, the purchase was executed with an average expected yield close to 10%. We also committed $20m to a vehicle that has been set up to support one global CLO manager in issuing US and European CLOs in compliance with retention rules (a Capitalized Manager Vehicle or "CMV"). Over several years this position will give us access to a portfolio of CLO equity positions from this manager with favourable terms. It is expected that the total commitment amount will be deployed within 3 to 4 years depending on CLO market activity. We expect this investment to deliver a mid-teen IRR performance. At the end of January 2017, Volta's Estimated NAV* was €310.8m or €8.50 per share. The GAV stood at €356.2m. In January, mark-to-market variations** of Volta's asset classes were: -0.4% for Synthetic Corporate Credit deals; +1.8% for CLO Equity tranches; +4% for CLO Debt tranches, -0.9% for Cash Corporate Credit deals; and +0.2% for ABS. During January, Volta generated the equivalent of €6.0m in interest and coupons net of repo costs (non-euro amounts translated into euro using end-of-month cross currency rates).  This brings the total cash amount generated during the last six months in terms of interest and coupons to €16.6m. Cash holdings or cash equivalent instruments at the end of January totaled €41.4m and we expect to invest in some recent transactions, including some Bank Balance Sheet transactions and a CLO warehouse, in the coming months. The current level of cash is higher than usual but reflects our view that credit markets are now quite fully valued and better opportunities will arise in due course. Contrary to previous months, the US Dollar depreciated somewhat against the Euro in January which has been slightly detrimental to Volta.  US Dollar exposure was approximately 26%. As noted in previous commentaries, we believe that the addition of duration to the portfolio via government bond exposure can provide a good hedge against further potential economic disappointments, providing that the exposure is built at prudent yield levels.  In November and December 2016 we added some duration to Volta through exposure to the US 5YR Note Future, with duration peaking at around 1.5 years. Following the recent rally in Treasuries we have partially taken profits on this position and at the end of January the duration overlay represented a modest 0.4 year of duration. We continue to see opportunities in several structured credit sectors including mezzanine and equity tranches of CLOs and Bank Balance Sheet transactions. We also expect to utilise CLO warehouse exposure as a way to access CLO equity positions with better economic terms. * It should be noted that approximately 10.5% of Volta's GAV comprises investments in funds for which the relevant NAVs as at the month-end date are normally available only after Volta's NAV has already been published. Volta's policy is to publish its own NAV on as timely a basis as possible in order to provide shareholders with Volta's appropriately up-to-date NAV information. Consequently, such investments in funds are valued using the most recently available NAV for each fund. The most recently available fund NAV was as at: 30 September 2016 for 0.9% of Volta's GAV and as at 31 December 2016 for 9.6% of Volta's GAV ** "Mark-to-market variation" is calculated as the Dietz-performance of the assets in each bucket, taking into account the Mark-to-Market of the assets at month-end, payments received from the assets over the period, and ignoring changes in cross currency rates. Nevertheless, some residual currency effects could impact the aggregate value of the portfolio when aggregating each bucket. ***** ABOUT VOLTA FINANCE LIMITED Volta Finance Limited is incorporated in Guernsey under The Companies (Guernsey) Law, 2008 (as amended) and listed on Euronext Amsterdam and the London Stock Exchange's Main Market for listed securities. Volta's home member state for the purposes of the EU Transparency Directive is the Netherlands. As such, Volta is subject to regulation and supervision by the AFM, being the regulator for financial markets in the Netherlands. Volta's investment objectives are to preserve capital across the credit cycle and to provide a stable stream of income to its shareholders through dividends. Volta seeks to attain its investment objectives predominantly through diversified investments in structured finance assets. The assets that the Company may invest in either directly or indirectly include, but are not limited to: corporate credits; sovereign and quasi-sovereign debt; residential mortgage loans; and, automobile loans. The Company's approach to investment is through vehicles and arrangements that essentially provide leveraged exposure to portfolios of such underlying assets. The Company has appointed AXA Investment Managers Paris an investment management company with a division specialised in structured credit, for the investment management of all its assets. ***** ABOUT AXA INVESTMENT MANAGERS AXA Investment Managers (AXA IM) is a multi-expert asset management company within the AXA Group, a global leader in financial protection and wealth management. AXA IM is one of the largest European-based asset managers with €679 billion in assets under management as of the end of June 2016. AXA IM employs approximately 2,399 people around the world. ***** This press release is distributed and published by AXA Investment Managers Paris ("AXA IM"), in its capacity as alternative investment fund manager (within the meaning of Directive 2011/61/EU, the "AIFM Directive") of Volta Finance Limited (the "Volta Finance") whose portfolio is managed by AXA IM. This press release is for information only and does not constitute an invitation or inducement to acquire shares in Volta Finance. Its circulation may be prohibited in certain jurisdictions and no recipient may circulate copies of this document in breach of such limitations or restrictions. This document is not an offer for sale of the securities referred to herein in the United States or to persons who are "U.S. persons" for purposes of Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or otherwise in circumstances where such offer would be restricted by applicable law. Such securities may not be sold in the United States absent registration or an exemption from registration from the Securities Act. Volta Finance does not intend to register any portion of the offer of such securities in the United States or to conduct a public offering of such securities in the United States. ***** This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). The securities referred to herein are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Past performance cannot be relied on as a guide to future performance. ***** This press release contains statements that are, or may deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "anticipated", "expects", "intends", "is/are expected", "may", "will" or "should". They include the statements regarding the level of the dividend, the current market context and its impact on the long-term return of Volta Finance's investments. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Volta Finance's actual results, portfolio composition and performance may differ materially from the impression created by the forward-looking statements. AXA IM does not undertake any obligation to publicly update or revise forward-looking statements. Any target information is based on certain assumptions as to future events which may not prove to be realised. Due to the uncertainty surrounding these future events, the targets are not intended to be and should not be regarded as profits or earnings or any other type of forecasts. There can be no assurance that any of these targets will be achieved. In addition, no assurance can be given that the investment objective will be achieved. The figures provided that relate to past months or years and past performance cannot be relied on as a guide to future performance or construed as a reliable indicator as to future performance. Throughout this review, the citation of specific trades or strategies is intended to illustrate some of the investment methodologies and philosophies of Volta Finance, as implemented by AXA IM. The historical success or AXA IM's belief in the future success, of any of these trades or strategies is not indicative of, and has no bearing on, future results. The valuation of financial assets can vary significantly from the prices that the AXA IM could obtain if it sought to liquidate the positions on behalf of the Volta Finance due to market conditions and general economic environment. Such valuations do not constitute a fairness or similar opinion and should not be regarded as such. Editor: AXA INVESTMENT MANAGERS PARIS, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6, Place de la Pyramide - 92908 Paris La Défense cedex, a company incorporated under the laws of France, having its register Management Company, holder of AMF Approval no. GP 92-08, issued on 7 April 1992.


News Article | March 1, 2017
Site: www.prweb.com

Today Infolinx System Solutions™, a leading provider of enterprise physical records management software, announced the upgrade to version 3.5 of Infolinx WEB™ by the York County Archives in Pennsylvania. This latest upgrade includes advanced space management and ECM integration with Laserfiche, expanding the county’s ability to manage both physical and electronic records. The York County Archives stores records for more than 40 county offices during various time periods throughout the county’s 250-year history. Stored records include marriages, deeds, wills, birth records, death records, and tax records. The Infolinx WEB 3.5 space management capability enables York County Archives users to efficiently manage available warehouse space. This feature allows users to identify and allocate open spaces for incoming inventory, as well as analyze space usage trends, providing insight into future facility needs. The upgraded application also includes ECM integration with Laserfiche, providing users with rapid, secure access to both physical and electronic records from the Infolinx WEB platform. In addition to deepened integrations with Microsoft SharePoint and Iron Mountain IM Link, new features of Infolinx WEB 3.5 include multiple language support, extended search capabilities, and configurable user-level email notifications to streamline in-app communication between users. About Infolinx® Infolinx System Solutions is a leading provider of DoD 5015.2-certified enterprise physical records management software. Full life-cycle records management for archives, records centers, and file rooms includes integrated Enterprise Content Management, third-party warehouse integration, robust searching, online requesting, complete audit history, location reconciliation, supply item ordering, retention schedule and legal holds management, integrated RFID technology, space management with charge-back functionality, extensive reporting capability, advanced security configuration, workflow email notifications, and legacy data sharing. Available as an on-premises or cloud-based solution, Infolinx maintains clients within a variety of industries and the public sector. To learn more, visit http://www.infolinx.com.


Patent
Im and Ryu | Date: 2011-02-23

A horn array antenna (1) for dual linear polarization receiving a first polarization wave and a second polarization wave comprises a plurality of horns (10) to which a mixed wave of the first polarization wave and the second polarization wave enters; a plurality of polarization filtering units (20) provided in each of the horns to separate the incident mixed wave into the first and second polarization waves; a first polarization guide (30) which guides the first polarization waves separated at the polarization filtering units; and a second polarization guide (50) which guides the second polarization waves separated at the polarization filtering units. An upper portion of each polarization filtering unit is formed as a quadrilateral space and each polarization filtering unit has four walls including a first, second, third and fourth walls. A stepped portion (25) is extended from a lower portion of the first wall to an interior of the polarization filtering unit, whereby a lower portion of the polarization filtering unit is formed as a quadrilateral space with a narrower width than that of the upper portion. An extended portion is formed on an upper portion of the stepped portion and a first polarization inlet is formed on the second wall opposite to the first wall to provide the first polarization wave to the first polarization guide.


News Article | February 15, 2017
Site: www.prweb.com

SyncDog, Inc., the leading ISV for mobile application containerization, today announced it has been named one of the 30 Most Admired Companies of the Year by Insights Success Magazine. The publication finds the most innovative companies and entrepreneurs in order to highlight their experiences, views, and approaches to development in their respective fields, and has featured SyncDog’s advancements in mobile security and app collaboration in its Most Admired Companies of 2016 edition. This acknowledgment is due in part to the subject matter expertise and leadership of CEO Jonas Gyllensvaan, as well as SyncDog’s innovative approach to enterprise mobile collaboration. The SyncDog SentinelSecure™ solution suite protects enterprise networks from the risk of cyber breach inherent in mobile computing sources, and offers a secure infrastructure as a general workspace and also to develop and deploy mobile apps securely. “Mobility is now a given for organizational objectives, but securing enterprise mobile data is often last thought of on the priority list,” said Gyllensvaan. “As cases of cyber intrusion rise, organizations must take the appropriate steps to secure their networks and out to their mobile endpoints.” The SentinelSecure™ containerized workspace provides a secure application platform that encrypts and transports data between the enterprise and secure, “sandboxed” applications running on employees’ and contractors’ mobile devices. The workspace protects client enterprise networks with a secure, partitioned FIPS 140-2 certified* container on both iOS and Android devices, and secures data both at rest and in transit using AES 256-bit encryption. The SentinelSecure™ container has been designed to address four main workflows for users accessing enterprise file stores and applications: Secure Communications, File Management, Secure Internet/Intranet Access, and Secure Location-based Services. A full suite of mobile-enabled productivity applications is available to support these workflows, including SharePoint, Enterprise Chat, Geo-location Services, DropBox, a Personal Information Management (PIM) suite, Office Suite, Office 365, Secure Mobile App Management & Development, File Sync, and many more. A full list of supported applications can be found here. Download the SentinelSecure™ datasheet here. To read the full write-up on SyncDog in Insights Success Magazine, click here. SyncDog has been actively building its partner ecosystem over the last year, securing certified APIs for the option to integrate SentinelSecure™ with a broad network of EMM providers. This flexibility allows customers the choice to deploy SentinelSecure™ as a standalone container or as a complementary layer of security to existing EMM investments. Certified SentinelSecure™ integrations include: SentinelSecure™ also has field integration with most name-brand EMM and MDM solutions. Insights Success is a global business solutions magazine that focuses distinctively on emerging and leading tech companies, their confrontational style of doing business, and their way of delivering effective, collaborative solutions to strengthen market share. It is the top publication for technology and business updates in the enterprise market. Insights Success Magazine talks about leaders from the world of technology, including CEOs, CIOs, VPs, and managers who have set benchmarks in the IT industry. For more information, visit insightssuccess.com. SyncDog is the leading independent software vendor (ISV) for building secure infrastructure frameworks that protect enterprise networks from cyber breach from mobile computing sources. The SentinelSecure™ product line for application containerization and IoT (Internet of Things) module monitoring provides the industry’s most proactive approach to securing enterprise mobile collaboration. The SentinelSecure™ data security solution delivers military-grade (FIPS 140-2 certified,* AES 256-bit) secure mobile device partitions or “containers” that can secure emails/contacts, calendar items, IM apps, Internet browsers, mobile file stores and other business apps provisioned on personal devices to be used in a BYOD or COPE (corporate owned personally enabled) setting. For more information on SyncDog products please visit syncdog.com/solutions


Patent
Im and Oh | Date: 2011-11-09

Provided is an air-filling type packaging material. The air-filling type packaging material includes a plurality of air-cells, an air passage, a communication passage, and a sealing member. The plurality of air-cells are divided by adhesion of an upper sheet and a lower sheet and performing a shock-absorbing function. The air passage is formed by adhesion of an upper sheet and a lower sheet such that external air flows into the air-cell. The communication passage is formed by adhesion of the upper and lower sheets, and connected to the air passage at one side thereof and connected to the air-cell to discharge air at the other side thereof. The sealing member is disposed in the communication passage between a portion thereof connected to an air passage and a portion thereof connected to the air-cell to prevent air filled in the air-cell from flowing backward.


The present invention relates to an apparatus for providing an object to be medically examined by blowing, wherein air is blown into a container in which an object to be medically examined is stored, so as to make the uniform distribution state of the object to be medically examined from the inside of the container, thereby ensuring the sameness of the object to be medically examined, which is to be extracted from the container.


Patent
Im | Date: 2015-05-27

Disclosed herein is a lid assembly for an airtight container in which an airtight container product may be directed in various manners by having an improved lid assembly such that a lid body and locking blade portions are integrally formed of different materials, and Tritan resin which has high transparency and is an eco-friendly material may be effectively applied to the lid assembly. To this end, the lid assembly for an airtight container includes a lid body (210) injection-molded with synthetic resin so as to cover an upper portion of an airtight container (100), the lid body (210) having a slot-shaped embedded groove (211) provided in a band form along an upper surface edge thereof and a packing groove (212) provided in a band form along a lower surface edge thereof, a lid-flange member (220) injection-molded with synthetic resin so as to surround an edge of the lid body (210) and have a ring shape after the lid-flange member (220) is inserted and arranged in a synthetic resin injection mold, the lid-flange member (220) including an inside hooking jaw (221) provided on an inner side thereof such that the inside hooking jaw (221) is hooked by an inside of the embedded groove (211) of the lid body (210), a flange (223) provided on an outer side thereof such that the flange (223) surrounds the edge of the lid body (210) and has an outside hooking jaw (222) hooked by an outer wall lower end of the packing groove (212), and locking blades (226) integrally formed at regular intervals along an edge of the flange (223) through snap-hinge portions (224) and having locking jaws (225) elastically hooked by a hooking protrusion (110) of the airtight container (100), and a silicon packing (230) installed in the packing groove (212) of the lid body (210) so as to come into close contact with the opened upper portion of the airtight container (100).

Loading IM collaborators
Loading IM collaborators